Indeed, when we determined the GI50 of our panel of melanoma cells for the DHFR inhibitors aminopterin, pyrimethamine and methrotrexate, we found that mutNRAS cells were significantly more resistant than mutBRAF cells (Figure 6C). The gene discussed is DHFR; the disease is melanoma.